• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION MOSAIC MITRAL BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION MOSAIC MITRAL BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 310
Device Problem Obstruction of Flow (2423)
Patient Problems Mitral Regurgitation (1964); Mitral Valve Stenosis (1965)
Event Date 06/16/2017
Event Type  Injury  
Manufacturer Narrative
Citation: dvir d.Tav in mitral surgical valves and rings: lessons from the vivid registry (transcatheter mitral valve-in-valve / valve-in-ring).Presented at transcatheter valve therapies 2017.Doi: not available ¿ slide presentation attached.Earliest date of publish used for event date (presented on jun 16, 2017).No unique device identifier (serial/lot) numbers were provided; without this information, it could not be determined whether these observations have been previously reported.Without return of the product, no definitive conclusion can be made regarding the clinical observations.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding a retrospective study of patients who underwent transcatheter mitral valve replacement of a previously implanted bioprosthetic mitral valve or annuloplasty ring.All data were collected from multiple centers through 2017.The study population included 437 patients (predominantly female; mean age 74 years; mean weight 69 kg), 67 of which were previously implanted with medtronic mosaic bioprosthetic valves, 49 were previously implanted with medtronic hancock bioprosthetic valves, 7 were previously implanted with medtronic duran ancore annuloplasty rings, and an unspecified number of which were implanted with medtronic melody bioprosthetic valves.It was also reported that 4 patients were previously implanted with ¿medtronic other¿ surgical mitral rings.No serial numbers were provided.Among all patients, the 30-day mortality rate was 8.5% and the 30-day cardiovascular mortality rate was 6.9%, respectively.Multiple manufacturers were noted in the literature; based on the available information, medtronic product was not directly associated with the deaths.Among all mosaic, hancock, duran ancore, and ¿medtronic other" patients, adverse events included: mitral stenosis, severe mitral regurgitation, or a combination of mitral stenosis and regurgitation requiring transcatheter mitral valve-in-valve or valve-in-ring implantation.Based on the available information, medtronic product was directly associated with the adverse events.Among all patients, post-transcatheter mitral valve replacement adverse events included: implantation of another transcatheter device, major stroke, left ventricular outflow tract obstruction, paravalvular leak, valve malpositioning, delayed valve malpositioning, residual stenosis, mitral regurgitation (greater than or equal to moderate), and elevated post procedural gradients.Based on the available information, the medtronic melody valve may have been associated with these adverse events.No additional adverse patient effects or product performance issues were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MOSAIC MITRAL BIOPROSTHETIC HEART VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key8755683
MDR Text Key149924886
Report Number2025587-2019-02134
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P990064
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Physician
Type of Report Initial
Report Date 07/02/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number310
Device Catalogue Number310
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/12/2019
Initial Date FDA Received07/02/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age74 YR
Patient Weight69
-
-